BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 3, 2004
View Archived Issues
Achillion Gets $10.4M As Part Of Series D, Names New CEO
Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)
Read More
Orion Tobacco Genome Work Extended To Net More Money
Read More
Spinout DCV Tech Focusing On Dendritic-Cell Cancer Vaccines
Read More
Other News To Note
Read More
Appointments And Advancements
Read More